Immunovant Statistics
NASDAQ: IMVTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
31.77-0.75 (-2.31%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Immunovant by the numbers
Immunovant has a market capitalization of $6.57 billion based on 206.95M shares outstanding. With trailing EPS of $-2.56, Immunovant is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.9% below its 50-day average and 2.3% below its 200-day average.
Average daily trading volume is 1.42M shares, or about $45.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IMVT valuation vs. peer median
| Metric | IMVT | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.57B | $6.72B | -2% |
| Avg. volume | 1.42M | 2.02M | -30% |
Peer median across 8 companies: IBRX, KOD, TWST, CGON, SRRK, ADPT, PCVX, KRYS.
Valuation
- Market cap
- $6.57B
- EPS (TTM)
- $-2.56
- Shares outstanding
- 206.95M
Price and trading
- Previous close
- 32.52
- Open
- 32.07
- Day range
- 31.62 – 32.77
- 52-week range
- 21.93 – 45.42
- 52-week change
- +40.64%
- Beta
- —
- Volume
- 702.87K
- Average volume
- 1.42M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 6.57B
- Forward Pe
- -11.26
- Eps
- -2.56
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 45.42
- Week52 Low
- 21.93
- Avg Volume
- 1.42M
- Shares Outstanding
- 206.95M
- Ma50
- 32.06
- Ma200
- 32.53
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -30.05%
- Pct From52w Low
- 44.87%